Replies to post #83 on BioDelivery Sciences International Inc. (BDSI)

[surf1944]

7:22AM On The Wires (WIRES) :

BioDelivery Sciences International (BDSI) announced that the last patient has completed the randomized portion of its Phase 3 clinical trial assessing the efficacy and safety of BEMA Buprenorphine for the treatment of moderate to severe chronic pain, signifying completion of the trial.